Lisata Therapeutics Stock Price on September 18, 2024
| LSTA Stock | USD 2.62 0.20 7.09% |
Below is the normalized historical share price chart for Lisata Therapeutics extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lisata Therapeutics stands at 2.62, as last reported on the 11th of December 2024, with the highest price reaching 2.88 and the lowest price hitting 2.62 during the day.
If you're considering investing in Lisata Stock, it is important to understand the factors that can impact its price. Lisata Therapeutics has Sharpe Ratio of -0.0542, which conveys that the firm had a -0.0542% return per unit of risk over the last 3 months. Lisata Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lisata Therapeutics' Standard Deviation of 3.08, mean deviation of 2.09, and Risk Adjusted Performance of (0.01) to check out the risk estimate we provide.
At present, Lisata Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 8.5 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 43.4 M. . At present, Lisata Therapeutics' Price To Sales Ratio is projected to drop slightly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 0.48, whereas Price Earnings Ratio is forecasted to decline to (1.11). Lisata Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of March 1999 | 200 Day MA 3.0487 | 50 Day MA 2.8868 | Beta 1.224 |
Lisata |
Sharpe Ratio = -0.0542
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LSTA |
Estimated Market Risk
| 3.12 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lisata Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lisata Therapeutics by adding Lisata Therapeutics to a well-diversified portfolio.
Price Book 0.6755 | Book Value 5.908 | Enterprise Value -12.9 M | Enterprise Value Ebitda 0.8161 | Shares Float 7 M |
Lisata Therapeutics Valuation on September 18, 2024
It is possible to determine the worth of Lisata Therapeutics on a given historical date. On September 18, 2024 Lisata was worth 3.05 at the beginning of the trading date compared to the closed value of 2.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lisata Therapeutics stock. Still, in general, we apply an absolute valuation method to find Lisata Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lisata Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lisata Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.00 | 3.24 | 2.97 | 3.10 | 25,538 | |
09/18/2024 | 3.05 | 3.20 | 2.95 | 2.95 | 31,635 |
| 2.91 | 3.14 | 2.91 | 3.02 | 13,527 |
| Backtest Lisata Therapeutics | | | Lisata Therapeutics History | | | Lisata Therapeutics Valuation | Previous | Next |
Lisata Therapeutics Trading Date Momentum on September 18, 2024
| On September 19 2024 Lisata Therapeutics was traded for 3.02 at the closing time. The top price for the day was 3.14 and the lowest listed price was 2.91 . The trading volume for the day was 13.5 K. The trading history from September 19, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 2.37% . The trading delta at closing time against the current closing price is 1.36% . |
Lisata Therapeutics Fundamentals Correlations and Trends
By evaluating Lisata Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lisata Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lisata financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lisata Therapeutics Stock history
Lisata Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lisata is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lisata Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lisata Therapeutics stock prices may prove useful in developing a viable investing in Lisata Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 8.1 M | 8.5 M | |
| Net Loss | -24.7 M | -26 M |
Lisata Therapeutics Quarterly Net Working Capital |
|
Lisata Therapeutics Stock Technical Analysis
Lisata Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lisata Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Lisata Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lisata Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Lisata Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lisata Therapeutics shares will generate the highest return on investment. By undertsting and applying Lisata Therapeutics stock market strength indicators, traders can identify Lisata Therapeutics entry and exit signals to maximize returns
Lisata Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lisata Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Lisata Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lisata to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.56) | |||
| Treynor Ratio | (0.13) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Lisata Stock analysis
When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |